Chris J. Dehaas

Statistics

Publications

Citations

460

H-Index

Active since

1988

Affiliations

GlaxoSmithKline (United States)(Current)

Nova Medical (United States)

Chris J. Dehaas is an author at GlaxoSmithKline (United States) specializing in pharmacology, long-acting muscarinic antagonists, and muscarinic receptor antagonism.

Publications per year

1988–2011

Publications

Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.

Larry R. Steranka, Donald C. Manning, Chris J. Dehaas et al. · Proceedings of the National Academy of Sciences · 1988 · 400 citations · Full text

Nursing, Pharmacology, Pain Medicine +16

[Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.

Stephen G. Farmer, Ronald M. Burch, Chris J. Dehaas et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 28 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Discovery of Novel and Long Acting Muscarinic Acetylcholine Receptor Antagonists

Jian Jin, Yonghui Wang, Dongchuan Shi et al. · Journal of Medicinal Chemistry · 2008 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The pre-clinical pharmacology of the inhaled muscarinic antagonist GSK573719 predicts once-daily clinical dosing

Dramane I. Lainé, Mark A. Luttmann, James J. Foley et al. · European Respiratory Journal · 2011 · 15 citations

Medicine, Pharmacology, Clinical Pharmacology +14

1–4 of 4